Andere talen Elutia Inc.

Aandelen

ELUT

US05479K1060

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 14-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,34 ^USD	-2,34%		+15,17%	+54,63%

09/05	Elutia Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
09/05	Transcript : Elutia Inc., Q1 2024 Earnings Call, May 09, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024	13/05
Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Elutia : Q1 2024 Financial Results Presentation	09/05
Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M	09/05
Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance	09/05
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	02/05
Elutia Planet MicroCap Showcase: VEGAS 2024 Presentation	02/05
Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1	24/04
Elutia Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07/03
Elutia Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
Earnings Flash (ELUT) ELUTIA Posts Q4 Revenue $5.9M, vs. Street Est of $6.6M	07/03
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024	07/03
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024	22/02
Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants	20/02
Elutia Regains Compliance with Nasdaq Listing Requirements	10/01
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance	18/12
Elutia Submits CanGaroo Antibiotic-Eluting Biomatrix for FDA Clearance	18/12
Elutia : The Wall Street Transcript	05/12
Elutia Inc. Amendments to Credit Agreement with SWK Funding LLC	15/11
Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Elutia Inc.

Aandelen

ELUT

US05479K1060

Andere talen

Filters